Alphatec Holdings, Inc. (NASDAQ:ATEC) Position Trimmed by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lowered its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATECGet Rating) by 95.6% in the 1st quarter, Holdings Channel reports. The fund owned 45,527 shares of the medical technology company’s stock after selling 979,269 shares during the period. Assenagon Asset Management S.A.’s holdings in Alphatec were worth $524,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. BNP Paribas Arbitrage SA grew its position in shares of Alphatec by 17.4% during the fourth quarter. BNP Paribas Arbitrage SA now owns 15,218 shares of the medical technology company’s stock worth $174,000 after acquiring an additional 2,259 shares during the last quarter. Cullen Frost Bankers Inc. grew its position in shares of Alphatec by 4.5% during the fourth quarter. Cullen Frost Bankers Inc. now owns 55,365 shares of the medical technology company’s stock worth $633,000 after acquiring an additional 2,385 shares during the last quarter. Swiss National Bank grew its position in shares of Alphatec by 2.3% during the fourth quarter. Swiss National Bank now owns 143,200 shares of the medical technology company’s stock worth $1,637,000 after acquiring an additional 3,200 shares during the last quarter. Amplius Wealth Advisors LLC bought a new position in shares of Alphatec during the fourth quarter worth about $68,000. Finally, Perkins Capital Management Inc. grew its position in Alphatec by 4.4% in the 1st quarter. Perkins Capital Management Inc. now owns 174,500 shares of the medical technology company’s stock valued at $2,007,000 after buying an additional 7,400 shares in the last quarter. Institutional investors own 53.52% of the company’s stock.

Insider Activity

In other Alphatec news, Director James L. L Tullis bought 7,500 shares of the company’s stock in a transaction dated Wednesday, June 15th. The shares were bought at an average price of $6.76 per share, for a total transaction of $50,700.00. Following the acquisition, the director now directly owns 187,558 shares of the company’s stock, valued at $1,267,892.08. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Alphatec news, Director James L. L. Tullis bought 7,500 shares of the company’s stock in a transaction dated Wednesday, June 15th. The shares were bought at an average price of $6.76 per share, for a total transaction of $50,700.00. Following the acquisition, the director now directly owns 187,558 shares of the company’s stock, valued at $1,267,892.08. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Miles sold 100,000 shares of the company’s stock in a transaction dated Wednesday, May 18th. The shares were sold at an average price of $8.34, for a total value of $834,000.00. Following the completion of the transaction, the chief executive officer now owns 5,858,634 shares in the company, valued at approximately $48,861,007.56. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 79,700 shares of company stock worth $563,300 and have sold 300,000 shares worth $2,339,500. 33.93% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ATEC. Needham & Company LLC decreased their target price on shares of Alphatec from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, May 26th. HC Wainwright increased their target price on shares of Alphatec from $19.00 to $20.00 in a research report on Friday, May 6th. StockNews.com initiated coverage on shares of Alphatec in a research report on Thursday, March 31st. They issued a “sell” rating for the company. Finally, Lake Street Capital reissued a “buy” rating and issued a $9.00 price target on shares of Alphatec in a report on Friday. One analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $17.50.

Alphatec Price Performance

ATEC stock opened at $6.69 on Tuesday. The company has a current ratio of 2.62, a quick ratio of 1.76 and a debt-to-equity ratio of 7.78. Alphatec Holdings, Inc. has a one year low of $5.73 and a one year high of $15.34. The firm has a market capitalization of $680.77 million, a PE ratio of -4.05 and a beta of 1.62. The firm has a 50-day moving average of $7.21 and a two-hundred day moving average of $9.74.

Alphatec (NASDAQ:ATECGet Rating) last posted its quarterly earnings data on Thursday, May 5th. The medical technology company reported ($0.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.14). Alphatec had a negative net margin of 60.83% and a negative return on equity of 147.10%. The firm had revenue of $70.93 million for the quarter, compared to analysts’ expectations of $67.72 million. On average, analysts forecast that Alphatec Holdings, Inc. will post -1.31 earnings per share for the current year.

About Alphatec

(Get Rating)

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement.

Featured Stories

Want to see what other hedge funds are holding ATEC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alphatec Holdings, Inc. (NASDAQ:ATECGet Rating).

Institutional Ownership by Quarter for Alphatec (NASDAQ:ATEC)

Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.